Applied Finance Capital Management, LLC Novartis Ag Transaction History

Applied Finance Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$106.13 - $120.89 $750,657 - $855,054	7,073 New	7,073 $814 Million
Q2 2024 Jul 31, 2024	BUY	$92.57 - $107.37 $118,304 - $137,218	1,278 Added 40.84%	4,407 $469 Million
Q4 2023 Feb 08, 2024	SELL	$92.27 - $101.54 $21,498 - $23,658	-233 Reduced 6.93%	3,129 $316 Million
Q3 2023 Nov 08, 2023	BUY	$94.73 - $105.13 $21,787 - $24,179	230 Added 7.34%	3,362 $342 Million
Q2 2023 Aug 14, 2023	BUY	$92.52 - $104.91 $29,236 - $33,151	316 Added 11.22%	3,132 $316 Million
Q1 2023 May 12, 2023	BUY	$80.03 - $92.81 $24,969 - $28,956	312 Added 12.46%	2,816 $259 Million
Q4 2022 Feb 15, 2023	BUY	$75.55 - $92.52 $189,177 - $231,670	2,504 New	2,504 $227 Million

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Applied Finance Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Applied Finance Capital Management, LLC with notifications on news.